Royal Bank of Canada
SONN

Royal Bank of Canada’s Sonnet BioTherapeutics SONN Stock Holding History

Royal Bank of Canada’s Portfolio SONN Stock Details SONN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Hold
0
– – – 7678
2022
Q3 		– Hold
0
– – – 7827
2019
Q2 		– Hold
0
– – – 7150
2019
Q1 		– Hold
0
– – – 7073
2018
Q4 		– Hold
0
– – – 7087
2018
Q3 		– Hold
0
– – – 6934
2018
Q2 		– Hold
0
– – – 6746
2018
Q1 		– Hold
0
– – – 6757
2017
Q4 		– Hold
0
– – – 6854
2017
Q3 		– Hold
0
– – – 6958

Other funds holding SONN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return